Please login to the form below

Not currently logged in
Email:
Password:

Roche's Chugai recalls Vesanoid in Japan

Roche's Japanese subsidiary Chugai has recalled its Vesanoid capsules for acute promyelocytic leukemia in Japan.

Roche's Japanese subsidiary Chugai has recalled its Vesanoid capsules for acute promyelocytic leukemia in Japan.

The recall follows the discovery of bovine-derived material sourced from Canada in a specific batch of the capsules imported from Roche, which is based in Switzerland.

Use of such material requires a partial amendment to the approval document for use in Japan.

Chugai and Roche had agreed not to export Vesanoid capsules using the material to Japan, but went ahead with the exportation anyway because Roche believed that its use was approved in the region.

Vesanoid had annual sales of approximately USD 24m for the twelve months ended April 2007, based on IMS sales data.

3rd August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics